Condition: Potassium-Competitive Acid Blocker · Proton Pump Inhibitor · Bismuth Based Quadruple Therapy · Sponsor: Tanta University
This study aims to compare the eradication rate, safety, and patient adherence between potassium-competitive acid blockers (P-CABs) and proton pump inhibitor-based bismuth quadruple therapy in patients with Helicobacter pylori infection.
This description comes directly from the study's public registry record.
Mohamed G Flefel, MD · 00201009156988 · mohamed.galal@med.tanta.edu.eg
Always discuss trial participation with your own doctor first.
| Tanta University | Tanta, El-Gharbia, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07165444